Lenalidomide Maintenance and Measurable Residual Disease in a Real-World Multiple Myeloma Transplanted Population Receiving Different Treatment Strategies Guided by Access to Novel Drugs in Brazil

SIMPLE SUMMARY: Lenalidomide maintenance (M-Len) after autologous stem cell transplantation (ASCT) improved survival outcomes in multiple myeloma (MM). The present work found that M-Len and measurable residual disease detected by next-generation flow cytometry (NGF) were independent prognostic facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Salgado, Anna Beatriz dos Santos, Magalhães, Roberto Jose Pessoa, Pontes, Robéria M., Barbosa, Eduarda da Silva, Flores-Montero, Juan, Sanoja-Flores, Luzalba, Land, Marcelo Gerardin Poirot, Pimenta, Glicinia, Dutra, Hélio dos Santos, Costa, Elaine S., Orfao, Alberto, Maiolino, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000507/
https://www.ncbi.nlm.nih.gov/pubmed/36900396
http://dx.doi.org/10.3390/cancers15051605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000507/
https://www.ncbi.nlm.nih.gov/pubmed/36900396
http://dx.doi.org/10.3390/cancers15051605

Ejemplares similares